Allmed Medical(SZ:002950) Sou Hu Cai Jing·2025-05-31 09:48Core Viewpoint - Aomei Medical (002950) is focusing on maintaining shareholder returns while investing in strategic upgrades and new product development in the medical device sector, particularly in advanced dressing products and overseas markets [1][2][3]. Company Performance - As of May 30, 2025, Aomei Medical's stock closed at 8.69 yuan, with a market capitalization of 5.503 billion yuan, ranking 56th in the medical device sector [1]. - The company reported a total revenue of 758.66 million yuan for Q1 2025, a year-on-year increase of 1.64%, while net profit decreased by 7.94% to 86.65 million yuan, with a net profit margin of 11.42% [5][7]. Dividend Policy - The company has distributed a total cash dividend of approximately 91.91 million yuan over the last three years, exceeding 30% of the average annual net profit, and plans to continue prioritizing shareholder returns despite reduced dividends in recent years due to strategic investments [1][2]. Product Development and Market Strategy - Aomei Medical is focusing on high-value medical devices, particularly in advanced dressing products, with plans to launch new functional dressing products in 2024 [2][3]. - The company aims to enhance its competitive edge through automation and smart technology in manufacturing, while also expanding its product offerings in the hygiene care sector [6][8]. International Market Presence - In 2024, Aomei Medical achieved overseas revenue of 275.65 million yuan, a 23.43% increase year-on-year, with a significant market share in developed regions such as the US and Europe [3][4]. - The company is actively expanding into emerging markets in the Middle East, South America, and Southeast Asia to reduce reliance on developed markets [4]. Industry Outlook - The medical dressing market is characterized as a stable growth sector with strong demand, and Aomei Medical is well-positioned to maintain its competitive advantage and market share [8].